Marret, Grégoire
Temam, Stéphane
Kamal, Maud
Even, Caroline
Delord, Jean-Pierre
Hoffmann, Caroline
Dolivet, Gilles
Malard, Olivier
Fayette, Jérôme
Capitain, Olivier
Vergez, Sébastien
Geoffrois, Lionel
Rolland, Frédéric
Zrounba, Philippe
Laccourreye, Laurent
Saada-Bouzid, Esma
Aide, Nicolas
Bénavent, Valérie
Klijianenko, Jerzy
Lamy, Constance
Girard, Elodie
Vacher, Sophie
Masliah-Planchon, Julien
de Koning, Leanne
Puard, Vincent
Borcoman, Edith
Jimenez, Marta
Bièche, Ivan
Gal, Jocelyn
Le Tourneau, Christophe
Article History
Received: 12 July 2023
Accepted: 13 December 2023
First Online: 18 December 2023
Competing interests
: C. Le Tourneau: Roche, Seattle Genetics, Rakuten, Nanobiotix, MSD, BMS, Merck Serono, AstraZeneca, GlaxoSmithKline, Novartis, Celgene, Exscientia, ALX Oncology, Seattle Genetics. M. Kamal: Roche. E. Borcoman: Eisai, Merck Serono, Sandoz, Daiichi Sankyo, Egle Tx.